Inspection Record

Athenex Pharma Solutions, LLC — FDA 483 Findings

US FDAInspected 2017-12-13Published 2020-01-28 4 findingsEquipment and facilityLabeling and packagingAseptic processing and sterility assurance

Inspectors Rachael A. MoliverThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

Equipment for adequate control over temperature is not provided when appropriate for the manufacture, processing, packing or holding of a drug product.

2Labeling and packaging

The labels of your outsourcing facility's drug products are deficient.

3Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the equipment to produce aseptic conditions.

4Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

About this record

Extracted automatically from the document US FDA published on 2020-01-28. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Athenex Pharma Solutions, LLC company profile — full history US FDA documents, 2020 Go to Findings search